Where to buy Eculizumab

Eculizumab (Eculizumab) is used to treat atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). In patients with paroxysmal nocturnal hemoglobinuria, it improved quality of life and reduced the need for transfusions but did not appear to affect the risk of death. It does not appear to change the risk of blood clots, myelodysplastic syndrome, acute myeloid leukemia, or aplastic anemia.

Eculizumab is also used to treat neuromyelitis optica spectrum disorder and generalized myasthenia gravis in adults who are anti-aquaporin-4 (AQ P4) antibody-positive. Eculizumab is also being explored to treat CD55 deficiency, also known as CHAPLE syndrome, a rare genetic disorder of the immune system. Following the labeling approval, patients treated with the drug were found to have positive clinical and laboratory results over an 18-month period, but this indication has not yet officially entered the label for eculizumab.

The patented drug Eculizumab has been launched in China and is covered by medical insurance. It is only reimbursed by qualified patients. The specification is The price of each box of 300mg (30ml) may be more than 3,000 yuan. This drug may be sold in domestic hospitals and other places, but patients must obtain the use of the drug with a doctor's prescription information. It is understood that the price of each box of the original Eculizumab drug sold overseas is more than 6,000 US dollars (the price may fluctuate due to the exchange rate). The ingredients of the original drug sold at home and abroad are basically the same, and the price of the original drug is still relatively expensive. At present, there are no generic drugs of eculizumab produced and put on the market. For specific prices and drug information of overseas drugs, please consult a medical consultant.